Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
金曜日, 9 04

Pulse Biosciences Inc

PLSENASDAQ
Trade with Public
Trade with Public
$54.71
2.033.85%
近くで: Sep 3, 5:00 PM EST
$55.53
0.821.5%
時間外: 7:50 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Pulse Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Pulse Biosciences (PLSE).

Price Target Range — 3 Quarters

Analyst Consensus — 3 Analysts

3Buy
Consensus RatingBuy# Analysts3Avg. Consensus PT$41Upside to Avg. PT-26.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 17, 2026NeedhamMike MatsonInitiateBuy$58
Aug 10, 2026Canaccord GenuityWilliam PlovanicPT RaiseBuy$32→$43
More with Benzinga EdgeGet Access

Analyst Ratings News

This Okta Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

Top Wall Street analysts changed their outlook on top stocks. See analyst ratings and price targets for PMT, ALAB.
Avi Kapoor

This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. See analyst rating changes on Benzinga's page. Analysts have positive views on ONTO stock.
Avi Kapoor

PRO
Needham Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $58

Needham analyst Mike Matson initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $58.
Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $43

Canaccord Genuity analyst William Plovanic maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $32 to $43.
Benzinga Newsdesk

PRO
Canaccord Genuity Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $32

Canaccord Genuity analyst William Plovanic initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $32.
Benzinga Newsdesk

PRO
Oppenheimer Initiates Coverage On Pulse Biosciences with Outperform Rating, Announces Price Target of $22

Oppenheimer analyst Suraj Kalia initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Outperform rating and announces Price Target of $22.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved